[Therapy for recurrent testicular cancer]

Area of Science:

• Oncology
• Medical Oncology
• Cancer Therapeutics

Context:

• Metastatic germ cell tumors (GCTs) present challenges in treatment, particularly after initial therapy failure or relapse.
• Salvage therapy is crucial for patients with persistent or recurring GCTs.
• Risk stratification is increasingly used to tailor salvage treatment strategies.

Purpose:

• To outline current salvage therapy approaches for metastatic germ cell tumors.
• To highlight the multimodal nature of salvage treatment, including chemotherapy, radiation, and surgery.
• To emphasize the importance of specialized centers for managing complex salvage protocols.

Summary:

• Salvage chemotherapy regimens (conventional and high-dose) are available for metastatic germ cell tumors with insufficient response or relapse.
• A multimodal approach integrating radiation for brain metastases and surgery for residual masses is recommended.
• Treatment selection is increasingly individualized based on patient risk stratification.

Impact:

• Salvage therapy for GCTs achieves a recurrence-free survival rate of approximately 50%, which is lower than that following primary chemotherapy.
• The complexity and significant treatment-related morbidity associated with salvage therapy necessitate its administration in specialized centers.
• Optimizing salvage strategies remains critical for improving outcomes in refractory or relapsed GCT patients.